Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of GSK plc(GSK) Shareholders
NEW YORK, NY / ACCESS Newswire / February 8, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Business Insider4d
GSK intends to commence GBP 2B share buyback program
Q4 2024 dividend of 16p declared; 61p FY 2024; 64p expected for 2025. GSK (GSK) now intends to commence a GBP 2B share buyback programme, to be implemented over the next 18 months. Published first ...
ETF Daily News5d
SG Americas Securities LLC Has $372,000 Stake in GSK plc (NYSE:GSK)
NYSE GSK opened at $34.91 on Tuesday. GSK plc has a 52 week low of $31.72 and a 52 week high of $45.92. The firm has a market capitalization of $72.34 billion, a P/E ratio of 22.67, a PEG ratio of ...
Insider Monkey3d
Why GSK plc (GSK) Went Up on Wednesday
In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...
in-cumbria.com3d
End of an era for pharmaceutical giant GSK
A task force has been set up to look into how to spend a £2m GSK legacy as the pharmaceutical giant closes its doors in Ulverston. Giles ...
The Financial Times4d
GSK launches £2bn buyback on strong HIV and cancer drugs sales
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of ...
London Evening Standard4d
GSK lifts long-term sales targets on new drug pipeline
It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024. GSK has increased its long-term sales guidance amid hopes for a boost from new speciality medicines ...
Yahoo Finance4d
FTSE 100 Live 05 February: Gold at new high, GSK lifts long-term sales outlook
GSK today increased its 2031 sales outlook to more than £40 billion, up from £38 billion amid stronger progress in its late-stage drugs pipeline. Total 2024 sales in GSK’s annual results published ...
pharmaphorum1d
GSK continues campaign for greater adult immunisation coverage
Ben Hargreaves examines the reasons supplied by the survey and why GSK is invested in the answers ... to a survey in the UK expressing high levels of mistrust. With a portfolio containing a ...
pharmaphorum1d
GSK bags breakthrough status for bone cancer drug
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
STAT4d
This week in biotech earnings so far
high costs, and insurance to get access to treatments that can help them. Here’s the gist: An Amgen drug called Ravicti, which is approved to treat urea cycle disorders, has also been shown in ...